Cipla
Signals mentioning Cipla
- Adani Airports to raise $1B for expansion, Airport City and non-aeronautical growth
- Sun Pharma, USV and Cipla deepen wellness bets as GLP-1 demand reshapes nutrition
- Bajaj Finance acquires 5% stake in generative-video platform TrueFan AI
- Maharashtra FDA cancels Cipla Pune warehouse sale licence; Cipla contests order
- Maharashtra FDA cancels Cipla arm’s Pune drug sales licences
- JPMorgan sees volume-led consumer staples recovery as ITC weighs on Nifty
- India pharma market grows 12.1% in July as Sun Pharma and Zydus outpace sector
- Cipla and Rocket India commit ₹300 crore to Karnataka capacity expansion
- Cipla and Rocket India plan ₹300 crore Karnataka manufacturing expansion
- Cipla Health takes Prolyte ORS awareness campaign into hospitals, transit and trade
- Cipla prioritises Yurpeak as sales nearly double, delaying semaglutide launch
- Cipla’s India sales rise 12% as it leans on consumer-health expansion
- Cipla Q1FY27 profit falls 39% despite record India sales
- HDFC Securities sees FY27 consumer recovery, but input volatility clouds margins
- India pharma market grows 16% as drugmakers enter US tariff-free transition
- Vishal Mega Mart, Meesho slated to report Q1 FY27 results on July 23
- GTRI flags proposed US generic-drug tariffs as major risk for Indian pharma exporters
- Indian generic drugmakers face potential US tariff shock from 2028
- Indian pharma stocks slide as Trump outlines tariffs of up to 200% on generic drugs
- Cipla Health's Omnigel debuts first sub-brand Maxstrong in 2% diclofenac category